Clinical Trials Logo

Food Allergy clinical trials

View clinical trials related to Food Allergy.

Filter by:

NCT ID: NCT04969653 Completed - Atopic Dermatitis Clinical Trials

The Incidence of Venous Thromboembolism in Atopic Dermatitis

Start date: June 21, 2021
Phase:
Study type: Observational

This study aims to investigate the incidence of venous thromboembolism in people who are diagnosed with atopic dermatitis.

NCT ID: NCT04856865 Completed - Food Allergy Clinical Trials

ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults

Start date: April 20, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of ADP101 in food allergic children and adults.

NCT ID: NCT04738565 Completed - Atopic Dermatitis Clinical Trials

An Innovative Probiotic Product With Antiallergic Properties

Start date: June 1, 2012
Phase: N/A
Study type: Interventional

Allergic diseases are currently one of the most important problem in medicine. Research confirms that probiotics administered during the formation of the intestinal ecosystem and the maturation of the immune system can positively influence the development of antiallergic mechanisms. The aim of the present randomized, double-blind, placebo controlled study was to evaluate the efficacy of the mixture of probiotic Lactobacillus rhamnosus ŁOCK 0900, Lactobacillus rhamnosus ŁOCK 0908, and Lactobacillus casei ŁOCK 0919 in children up to the age 2 with atopic dermatitis and food allergy to cow's milk proteins. Children received the mixture of Lactobacillus strains for 3 months every day in the daily dose of a billion bacteria or a placebo (maltodextrin). Primary outcomes included the effects of probiotic treatment on the severity of symptoms assessed with SCORing atopic dermatitis (SCORAD) index. Secondary endpoints included assessment of total IgE and selected cytokine levels. Cytokines were evaluated in supernatants obtained from peripheral blood cultures of randomly selected 20 patients from each group. The primary and secondary outcomes were assessed at 3 time points: at baseline, after the finishing the administration of probiotic/placebo, and after 9 months of follow up.

NCT ID: NCT04476433 Completed - Asthma Clinical Trials

Intervention in Chronic Pediatric Patients and Their Families.

FACTORADAPT
Start date: February 4, 2019
Phase: N/A
Study type: Interventional

This project consists of a psychological intervention in patients and their families with different chronic diseases in order to carry out a comparative study between medical pathologies to know which are the protective or risk variables for the adaptation to the disease.

NCT ID: NCT04345185 Completed - Obesity Clinical Trials

Effects of Infant Egg Consumption on Child Health and Cognition Development

Start date: January 1, 1999
Phase:
Study type: Observational

The objective of this study is to examine how infant egg consumption (age of introduction and frequency of intake) influences physical growth, obesity, cardio-metabolic health, risk of food allergy, and cognition development in mid-childhood and adolescence.

NCT ID: NCT04186949 Completed - Asthma Clinical Trials

Early Origins of Allergy and Asthma

ARIES
Start date: October 9, 2018
Phase:
Study type: Observational

Birth cohort study with recruitment during pregnancy to determine prenatal and perinatal conditions, as well as genetic and epigenetic factors, that participate in the early setting of immune responses, and the role of these in the later determination of the risk of allergic diseases, asthma, and metabolic conditions in the offspring.

NCT ID: NCT04037176 Completed - Food Allergy Clinical Trials

Behandling af Boern Med Foedevareallergi Med Omalizumab (Xolair)

Start date: November 1, 2019
Phase: Phase 4
Study type: Interventional

Food allergy is a common disease in childhood affecting up to 8% of children in Westernized countries. About 30 percent of children with food allergies are allergic to more than one food, most often milk, egg, wheat, peanut and tree nut. Peanut and hazelnut are common triggers of severe and potentially fatal food-induced anaphylactic reactions. Currently, there is no curative treatment for food allergy. Novel therapies for this potentially life-threatening condition are therefore much needed.

NCT ID: NCT03907397 Completed - Food Allergy Clinical Trials

Immune and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy

CAFETERIA
Start date: August 5, 2019
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to determine whether allowing ingestion of sub-threshold amounts of peanut in those with a high threshold (tolerate at least 143 mg peanut protein on supervised double-blind, placebo-controlled oral food challenge [DBPCFC]) will be associated with attaining even higher thresholds over time in children with high threshold peanut allergy compared to those avoiding peanut. The secondary clinical objectives include assessing the development of sustained unresponsiveness (SU, a surrogate term for tolerance without daily ingestion), effects on quality of life, and safety compared to those avoiding peanut. Additionally, this study will phenotype the allergic response to peanut based on threshold and response to exposure. Mechanistic study objectives will determine the immune and molecular basis of the high threshold endotype, identify predictors of response to exposure, and determine mechanisms and biomarkers of remission.

NCT ID: NCT03871998 Completed - Food Allergy Clinical Trials

Short-term Topical Application to Prevent Atopic Dermatitis

STOP AD
Start date: April 16, 2019
Phase: N/A
Study type: Interventional

This is a randomised, open-label, controlled study designed to investigate the effect of short-term neonatal skin barrier protection using a commercially available moisturiser on the prevention of atopic dermatitis and food allergy in high risk children.

NCT ID: NCT03826576 Completed - Food Allergy Clinical Trials

Healthy Meals: A Restaurant-based Study to Promote Healthy and Allergy Adapted Diet

HealthyMeals
Start date: February 21, 2019
Phase: N/A
Study type: Interventional

This study evaluates the effect of a multicomponent intervention applied to restaurant staff about training and nutritional quality of menu improvement, in order to promote a healthy diet and a better management of allergies and intolerances addressed to each family member satisfying the customers with specific needs (allergies and intolerances of food).